Cargando…
Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines
This article provides a systematic assessment of the efficacy, risks, and methodological quality of evidence from five major publicly available vaccine trials. Results from Pfizer-BioNTech mRNA, Moderna-US NIH mRN-1273, AstraZeneca-Oxford ChAdOx1 nCov-19, Gamaleya GamCovidVac (Sputnik V), and Ad26.C...
Autores principales: | Albers, Jacob R., Brown, Jeffrey B., Charkowick, Shaun V., Ram, Natasha, Klocksieben, Farina A., Kumar, Ambuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788423/ https://www.ncbi.nlm.nih.gov/pubmed/36560476 http://dx.doi.org/10.3390/vaccines10122065 |
Ejemplares similares
-
Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic review
por: Reljic, Tea, et al.
Publicado: (2017) -
Author Reply
por: Charan, Jaykaran, et al.
Publicado: (2016) -
Hospitalizations Are Increasing in Distal Upper Extremity Fractures
por: Brown, Jeffrey B, et al.
Publicado: (2023) -
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis
por: Razavi, Marianne, et al.
Publicado: (2019) -
Benefits of Prior Authorizations
por: Forrester, Caroline
Publicado: (2020)